Project affiliate - Aviva Plc logo image

Research into childhood cancer

by Helen Hawley Hughes in Salford, England, United Kingdom


£10,000 stretch target 3 days left
100% 142 supporters
Keep what you raise – this project will receive all pledges made by 7th December 2021 at 12:00pm

We want to raise money to fund more research into childhood cancer. We want to find kinder more targeted treatments for children with cancer

by Helen Hawley Hughes in Salford, England, United Kingdom

New stretch target

£10,000 would enable us to fund a pump priming grant into more detailed research of successful data. 


Kidscan Children’s Cancer Research fund research into new, gentler and more effective treatments for children with cancer.

Cancer is the leading cause of death in children in the UK. Of the 1645 diagnosed every year, sadly over 20% of those children will not survive because treatment options are limited. Of those who do survive, 60% will go on to develop life-long health problems known as late-effects, caused by the treatments used to save their lives.

Meet Matty.


In December 2016 aged 12 years old, Matty started getting headaches and being sick. After a visit to the GP was followed up with a CT scan, he was diagnosed with Medulloblastoma, a rare brain tumour. Matty had surgery to remove the tumour followed by 6 weeks of radiotherapy and 14 months of chemotherapy. 6 months after he completed his treatment sadly Matty relapsed, so he needed a further 6 months of intrathecal chemotherapy. His tumours could no longer be seen so treatment was discontinued. Unfortunately, at the beginning of the first lockdown in 2020 Matty relapsed again. 1632228834_thumbnail_img_2908_(1).jpg

Relapsing during lockdown was hard for Matty, as he no longer had the face-to-face support network of friends that he would usually discuss his concerns with. He was meant to have treatment at the local Gamma knife treatment centre but it was closed to children due to Covid risks, so he had to make the journey to London for his treatment. Having treatment in lockdown also meant that Matty couldn't have both his mum and dad to support him through new treatments.

Why do we need help?

Today 4 children will be diagnosed with cancer in the UK.

Because of harsh treatments, 60% of those who survive will suffer "late effects". This happens because most current treatments such as chemotherapy are designed for adults, to attack multiplying cancerous cells. But given to children, these treatments also damage growing healthy cells within the body. This can lead to mobility issues, heart, lung and other organ problems, development issues, hearing loss and in some cases infertility, that can appear long after treatment has finished.

By developing therapies targeting the changes that occur only in cancerous cells, Kidscan aims to create a world where every child can survive cancer and thrive throughout adulthood, without suffering late-effects.

Covid-19 had a big impact on our charity as we lost over half of our income. Although we are starting to recover, we need help to ensure that the research continues.


Sadly between 2-3 children out of every 10 children in Britain diagnosed with cancer will not survive to adulthood.

In the UK only 3.5% of medical research spend is dedicated to fixing this problem. Kidscan is one of the only charities in the UK focused solely on specifically raising awareness of childhood cancer and the risks of late effects to promote early diagnosis and the development of safer more effective treatments.

Every donation we receive goes to funding research dedicated to childhood cancer. The pandemic has been difficult for Kidscan; we have seen an increase in researchers with projects looking for funding but at the same time we have seen a reduction in our income. We want to fund as much research as we possibly can. With the help of supporters like you, we can achieve this.


How can you help?

We are crowdfunding with the help of the Aviva Community fund, to pay for 2 student research placements.

One example of research our students would like to undertake is finding new ways to identify treatment-induced drug resistance in childhood leukaemia patients.

Leukaemia is the most common form of childhood cancer, responsible for 31% of childhood cancer cases in the UK. The treatment of leukaemia often involves multiple drug treatments, which are often needed as a patient’s leukaemia cells can develop resistance to the original drug being given.

Treatment with more than one drug has dramatically increased childhood cancer survival rates to over 80% today, however, these treatments cause tremendous damage to healthy cells within the child’s body. This damage can leave childhood cancer survivors with a series of late-effects such as hearing loss, organ and bone problems and even infertility. In fact, two thirds of childhood cancer survivors will suffer some form of late-effects of treatment, and the more therapies necessary during the course of treatment the more severe the late effects can become.

Our researchers want to develop new ways of detecting drug resistant cancer cells in the body which will in turn lead to new targeted drugs and therapies.

Find our more about Kidscan

To find out more about the research Kidscan is funding and the children we are supporting check out our website:



This project offers rewards in return for your donation.

£20 or more

£20 Reward

A heartfelt thank you email from everyone at Kidscan

£30 or more

£30 Reward

You will receive a personalised certificate to show you are an amazing supporter.

Show your support

Payment and personal details are protected